These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17458249)

  • 1. [Hypertriglyceridemia].
    Yoshida H; Yanai H
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():378-84. PubMed ID: 17458249
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of CHD: the role of elevated triglycerides.
    Watson KE
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):4-6, 13-4. PubMed ID: 18510281
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population.
    Ascaso JF; Millán J; Mateo-Gallego R; Ruiz A; Suarez-Tembra M; Borrallo RM; Zambon D; Gonzalez-Santos P; Peres-de-Juan M; Ros E;
    Eur J Intern Med; 2011 Apr; 22(2):177-81. PubMed ID: 21402249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypertriglyceridemias: risk and management. Introduction.
    Assmann G; Gotto AM; Paoletti R
    Am J Cardiol; 1991 Jul; 68(3):1A-4A. PubMed ID: 1853841
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
    Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
    [No Abstract]   [Full Text] [Related]  

  • 6. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
    Grundy SM; Vega GL
    Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status of hypertriglyceridemia as a risk factor for coronary heart disease.
    Avins AL; Haber RJ; Hulley SB
    Clin Lab Med; 1989 Mar; 9(1):153-68. PubMed ID: 2647371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
    Rankin FM; Cohen JD
    J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertriglyceridemia as vascular risk factor: findings of the international evaluation.
    Can J Cardiol; 1991 Sep; 7(7):XI-XII. PubMed ID: 1933633
    [No Abstract]   [Full Text] [Related]  

  • 10. Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese.
    Zhao D; Grundy SM; Wang W; Liu J; Zeng Z; Wang W; Wu Z
    Am J Cardiol; 2007 Sep; 100(5):835-9. PubMed ID: 17719329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease?
    Després JP
    CMAJ; 1993 Apr; 148(8):1339-40. PubMed ID: 8462056
    [No Abstract]   [Full Text] [Related]  

  • 12. Focus on hypertriglyceridemia: improving patient outcomes.
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):3. PubMed ID: 18510280
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolic syndrome and small, dense LDL].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():391-9. PubMed ID: 17458251
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk associated with the metabolic syndrome versus the sum of its individual components.
    Sundström J; Vallhagen E; Risérus U; Byberg L; Zethelius B; Berne C; Lind L; Ingelsson E
    Diabetes Care; 2006 Jul; 29(7):1673-4. PubMed ID: 16801601
    [No Abstract]   [Full Text] [Related]  

  • 15. Aging of progenitor cells contributes to atherosclerosis.
    SoRelle R
    Circulation; 2003 Jul; 108(4):e9006-7. PubMed ID: 12885741
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dyslipidemia as coronary risk factor].
    Rocha E
    Rev Port Cardiol; 1992 Apr; 11(4):363-8. PubMed ID: 1632992
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atherosclerotic vascular disease and its prevention in metabolic syndrome].
    Yokote K; Saito Y
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():30-4. PubMed ID: 17458191
    [No Abstract]   [Full Text] [Related]  

  • 19. Triglycerides emerge as a coronary risk factor.
    Harv Heart Lett; 1998 Jul; 8(11):6. PubMed ID: 9666754
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients.
    Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Kalboussi N; Ben Rejeb N; Nabli N; Ben Abdelaziz A; Boughazala E; Bouslama A
    Metab Syndr Relat Disord; 2010 Dec; 8(6):515-22. PubMed ID: 20715933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.